Switch to:
More From Other Websites
Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia Sep 19 2017
Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners Sep 19 2017
Portland's Sightbox sold to health care behemoth Sep 18 2017
3 Dividend Stocks Ideal for Your Golden Years Sep 18 2017
My Buy and Sell Ratings on the 20 Largest Stocks Sep 18 2017
Catalyst (CPRX) Focused on Two Lead Pipeline Candidates Sep 18 2017
J&J's (JNJ) Psoriasis Drug Guselkumab Gets CHMP Nod in EU Sep 18 2017
Neos Therapeutics ADHD Drug Adzenys Receives Approval in US Sep 18 2017
Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion Sep 18 2017
See what the IHS Markit Score report has to say about Johnson & Johnson. Sep 18 2017
Abbott Laboratories’ 375th Consecutive Quarterly Dividend Sep 18 2017
3 Stocks to Hold for the Next Century Sep 17 2017
Don't Make This Huge Mistake With Celgene Sep 17 2017
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright Sep 17 2017
The Smartest Move Johnson & Johnson Has Made All Year Sep 15 2017
[$$] JNJ May Benefit From Celltrion Issues Sep 15 2017
Ridiculously Weak U.S. Dollar Will Make These 10 Companies Huge Winners Sep 15 2017
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs Sep 15 2017
Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study Sep 15 2017
Johnson & Johnson Is Getting Ready for Another Upside Breakout Sep 15 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK